Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
BACKGROUND<br/> The replication-competent recombinant vesicular stomatitis virus (rVSV)–based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety and immunogenicity testing before its use in West Africa. <br/><br/>METHODS<br/> We performed...
| Κύριοι συγγραφείς: | , , , |
|---|---|
| Μορφή: | Journal article |
| Έκδοση: |
Massachusetts Medical Society
2016
|